Listening to silence and understanding nonsense: exonic mutations that affect splicing (original) (raw)

• Burge, C. B., Tuschl, T. & Sharp, P. A. in The RNA World II (eds Gesteland, R. F., Cech, T. R. & Atkins, J. F.) 525–560 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1999).
  Google Scholar
• Will, C. L. & Lührmann, R. Spliceosomal U snRNP biogenesis, structure and function. Curr. Opin. Cell Biol. 13, 290–301 (2001).
  CAS PubMed Google Scholar
• Sun, H. & Chasin, L. A. Multiple splicing defects in an intronic false exon. Mol. Cell. Biol. 20, 6414–6425 (2000).This study provides a systematic sequence analysis of the numerous pseudo-exons in HPRT , and investigates some of the features that distinguish authentic exons from pseudo-exons.
  CAS PubMed PubMed Central Google Scholar
• International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 409, 860–921 (2001).
• Venter, J. C. et al. The sequence of the human genome. Science 291, 1304–1351 (2001).
  CAS PubMed Google Scholar
• Graveley, B. R. Alternative splicing: increasing diversity in the proteomic world. Trends Genet. 17, 100–107 (2001).
  CAS PubMed Google Scholar
• Schmucker, D. et al. Drosophila Dscam is an axon guidance receptor exhibiting extraordinary molecular diversity. Cell 101, 671–684 (2000).The combinatorial use of alternative exons allows this single gene in Drosophila to express 38,016 potential isoforms.
  CAS PubMed Google Scholar
• Adams, M. D. et al. The genome sequence of Drosophila melanogaster. Science 287, 2185–2195 (2000).
  Article PubMed Google Scholar
• Modrek, B. & Lee, C. A genomic view of alternative splicing. Nature Genet. 30, 13–19 (2002).
  CAS PubMed Google Scholar
• Graveley, B. R. Sorting out the complexity of SR protein functions. RNA 6, 1197–1211 (2000).
  CAS PubMed PubMed Central Google Scholar
• Hastings, M. L. & Krainer, A. R. Pre-mRNA splicing in the new millennium. Curr. Opin. Cell Biol. 13, 302–309 (2001).
  CAS PubMed Google Scholar
• López, A. J. Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. Annu. Rev. Genet. 32, 279–305 (1998).
  PubMed Google Scholar
• Liu, H. X., Zhang, M. & Krainer, A. R. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev. 12, 1998–2012 (1998).
  CAS PubMed PubMed Central Google Scholar
• Schaal, T. D. & Maniatis, T. Multiple distinct splicing enhancers in the protein-coding sequences of a constitutively spliced pre-mRNA. Mol. Cell. Biol. 19, 261–273 (1999).
  CAS PubMed PubMed Central Google Scholar
• Blencowe, B. J. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem. Sci. 25, 106–110 (2000).
  CAS PubMed Google Scholar
• Birney, E., Kumar, S. & Krainer, A. R. Analysis of the RNA-recognition motif and RS and RGG domains: conservation in metazoan pre-mRNA splicing factors. Nucleic Acids Res. 21, 5803–5816 (1993).
  CAS PubMed PubMed Central Google Scholar
• Robberson, B. L., Cote, G. J. & Berget, S. M. Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol. Cell. Biol. 10, 84–94 (1990).This paper proposed the concept that the unit of recognition during the early stages of spliceosome assembly is the exon, rather than the intron, such that there is communication between the 3′ and 5′ splice sites that flank an exon.
  CAS PubMed PubMed Central Google Scholar
• Zuo, P. & Maniatis, T. The splicing factor U2AF35 mediates critical protein–protein interactions in constitutive and enhancer-dependent splicing. Genes Dev. 10, 1356–1368 (1996).
  CAS PubMed Google Scholar
• Graveley, B. R., Hertel, K. J. & Maniatis, T. The role of U2AF35 and U2AF65 in enhancer-dependent splicing. RNA 7, 806–818 (2001).
  CAS PubMed PubMed Central Google Scholar
• Kan, J. L. & Green, M. R. Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor. Genes Dev. 13, 462–471 (1999).
  CAS PubMed PubMed Central Google Scholar
• Zhu, J. & Krainer, A. R. Pre-mRNA splicing in the absence of an SR protein RS domain. Genes Dev. 14, 3166–3178 (2000).
  CAS PubMed PubMed Central Google Scholar
• Zhu, J., Mayeda, A. & Krainer, A. R. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol. Cell 8, 1351–1361 (2001).This paper showed that a factor that is bound to an exonic splicing silencer can repress exon recognition, depending on the factors that are available to recognize the splicing enhancers elsewhere in the exon.
  CAS PubMed Google Scholar
• Tanaka, K., Watakabe, A. & Shimura, Y. Polypurine sequences within a downstream exon function as a splicing enhancer. Mol. Cell. Biol. 14, 1347–1354 (1994).The first systematic analysis of a purine-rich exonic splicing enhancer, which showed that the purine-rich base composition is not sufficient to promote splicing.
  CAS PubMed PubMed Central Google Scholar
• Ramchatesingh, J., Zahler, A. M., Neugebauer, K. M., Roth, M. B. & Cooper, T. A. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol. Cell. Biol. 15, 4898–4907 (1995).
  CAS PubMed PubMed Central Google Scholar
• Watakabe, A., Tanaka, K. & Shimura, Y. The role of exon sequences in splice site selection. Genes Dev. 7, 407–418 (1993).
  CAS PubMed Google Scholar
• Staknis, D. & Reed, R. SR proteins promote the first specific recognition of pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol. Cell. Biol. 14, 7670–7682 (1994).
  CAS PubMed PubMed Central Google Scholar
• Tian, H. & Kole, R. Selection of novel exon recognition elements from a pool of random sequences. Mol. Cell. Biol. 15, 6291–6298 (1995).This paper reports the development of the functional SELEX approach to identify sequences that can enhance splicing. Enhancer sequences were found to be very diverse and not always purine rich.
  CAS PubMed PubMed Central Google Scholar
• Woerfel, G. & Bindereif, A. In vitro selection of exonic splicing enhancer sequences: identification of novel CD44 enhancers. Nucleic Acids Res. 29, 3204–3211 (2001).
  CAS PubMed PubMed Central Google Scholar
• Coulter, L. R., Landree, M. A. & Cooper, T. A. Identification of a new class of exonic splicing enhancers by in vivo selection. Mol. Cell. Biol. 17, 2143–2150 (1997).
  CAS PubMed PubMed Central Google Scholar
• Schaal, T. D. & Maniatis, T. Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences. Mol. Cell. Biol. 19, 1705–1719 (1999).
  CAS PubMed PubMed Central Google Scholar
• Liu, H. X., Chew, S. L., Cartegni, L., Zhang, M. Q. & Krainer, A. R. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions. Mol. Cell. Biol. 20, 1063–1071 (2000).
  CAS PubMed PubMed Central Google Scholar
• Tacke, R. & Manley, J. L. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J. 14, 3540–3551 (1995).
  CAS PubMed PubMed Central Google Scholar
• Fairbrother, W. G. & Chasin, L. A. Human genomic sequences that inhibit splicing. Mol. Cell. Biol. 20, 6816–6825 (2000).
  CAS PubMed PubMed Central Google Scholar
• Caputi, M. et al. A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon. Nucleic Acids Res. 22, 1018–1022 (1994).
  CAS PubMed PubMed Central Google Scholar
• Amendt, B. A., Si, Z. H. & Stoltzfus, C. M. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol. Cell. Biol. 15, 4606–4615 (1995).
  CAS PubMed PubMed Central Google Scholar
• Staffa, A. & Cochrane, A. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 15, 4597–4605 (1995).
  CAS PubMed PubMed Central Google Scholar
• Zheng, Z. M., Huynen, M. & Baker, C. C. A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly. Proc. Natl Acad. Sci. USA 95, 14088–14093 (1998).
  CAS PubMed PubMed Central Google Scholar
• Del Gatto-Konczak, F., Olive, M., Gesnel, M. C. & Breathnach, R. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer. Mol. Cell. Biol. 19, 251–260 (1999).
  CAS PubMed PubMed Central Google Scholar
• Chew, S. L., Baginsky, L. & Eperon, I. C. An exonic splicing silencer in the testes-specific DNA ligase IIIβ exon. Nucleic Acids Res. 28, 402–410 (2000).
  CAS PubMed PubMed Central Google Scholar
• Smith, C. W. & Valcárcel, J. Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem. Sci. 25, 381–388 (2000).
  CAS PubMed Google Scholar
• Wagner, E. J. & Garcia-Blanco, M. A. Polypyrimidine tract binding protein antagonizes exon definition. Mol. Cell. Biol. 21, 3281–3288 (2001).
  CAS PubMed PubMed Central Google Scholar
• Dreyfuss, G., Matunis, M. J., Piñol-Roma, S. & Burd, C. G. hnRNP proteins and the biogenesis of mRNA. Annu. Rev. Biochem. 62, 289–321 (1993).
  CAS PubMed Google Scholar
• Krecic, A. M. & Swanson, M. S. hnRNP complexes: composition, structure, and function. Curr. Opin. Cell Biol. 11, 363–371 (1999).
  CAS PubMed Google Scholar
• Chen, C. D., Kobayashi, R. & Helfman, D. M. Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat β-tropomyosin gene. Genes Dev. 13, 593–606 (1999).
  CAS PubMed PubMed Central Google Scholar
• Blanchette, M. & Chabot, B. Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J. 18, 1939–1952 (1999).
  CAS PubMed PubMed Central Google Scholar
• Chabot, B. Directing alternative splicing: cast and scenarios. Trends Genet. 12, 472–478 (1996).
  CAS PubMed Google Scholar
• Krawczak, M., Reiss, J. & Cooper, D. N. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum. Genet. 90, 41–54 (1992).This thorough survey of human mutations shows that ∼15% of point mutations that are associated with human genetic diseases affect the conserved signals at the ends of introns and result in aberrant splicing patterns.
  CAS PubMed Google Scholar
• Ars, E. et al. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum. Mol. Genet. 9, 237–247 (2000).
  CAS PubMed Google Scholar
• Teraoka, S. N. et al. Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. Am. J. Hum. Genet. 64, 1617–1631 (1999).In references 48 and 49 , many mutations in NF1 and ATM , respectively, were systematically analysed at the gene, mRNA and protein level. The authors show that ∼50% of the mutations, including several in the coding sequence, result in aberrant splicing patterns.
  CAS PubMed PubMed Central Google Scholar
• Hentze, M. W. & Kulozik, A. E. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96, 307–310 (1999).
  CAS PubMed Google Scholar
• Mendell, J. T. & Dietz, H. C. When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell 107, 411–414 (2001).
  CAS PubMed Google Scholar
• Dietz, H. C. et al. The skipping of constitutive exons in vivo induced by nonsense mutations. Science 259, 680–683 (1993).This study provided the first evidence that certain nonsense mutations can affect the fidelity of pre-mRNA splicing, and cause mutation-containing exons to be skipped.
  CAS PubMed Google Scholar
• Dietz, H. C. & Kendzior, R. J. Jr. Maintenance of an open reading frame as an additional level of scrutiny during splice site selection. Nature Genet. 8, 183–188 (1994).
  CAS PubMed Google Scholar
• Gersappe, A., Burger, L. & Pintel, D. J. A premature termination codon in either exon of minute virus of mice P4 promoter-generated pre-mRNA can inhibit nuclear splicing of the intervening intron in an open reading frame-dependent manner. J. Biol. Chem. 274, 22452–22458 (1999).
  CAS PubMed Google Scholar
• Gersappe, A. & Pintel, D. J. A premature termination codon interferes with the nuclear function of an exon splicing enhancer in an open reading frame-dependent manner. Mol. Cell. Biol. 19, 1640–1650 (1999).
  CAS PubMed PubMed Central Google Scholar
• Muhlemann, O. et al. Precursor RNAs harboring nonsense codons accumulate near the site of transcription. Mol. Cell 8, 33–43 (2001).
  CAS PubMed Google Scholar
• Urlaub, G., Mitchell, P. J., Ciudad, C. J. & Chasin, L. A. Nonsense mutations in the dihydrofolate reductase gene affect RNA processing. Mol. Cell. Biol. 9, 2868–2880 (1989).
  CAS PubMed PubMed Central Google Scholar
• Maquat, L. E. When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. RNA 1, 453–465 (1995).
  CAS PubMed PubMed Central Google Scholar
• Li, S. & Wilkinson, M. F. Nonsense surveillance in lymphocytes? Immunity 8, 135–141 (1998).
  CAS PubMed Google Scholar
• Brogna, S. Pre-mRNA processing: insights from nonsense. Curr. Biol. 11, R838–R841 (2001).
  CAS PubMed Google Scholar
• Etchison, D. & Etchison, J. R. Monoclonal antibody-aided characterization of cellular p220 in uninfected and poliovirus-infected HeLa cells: subcellular distribution and identification of conformers. J. Virol. 61, 2702–2710 (1987).
  CAS PubMed PubMed Central Google Scholar
• Dostie, J., Lejbkowicz, F. & Sonenberg, N. Nuclear eukaryotic initiation factor 4E (eIF4E) colocalizes with splicing factors in speckles. J. Cell Biol. 148, 239–247 (2000).
  CAS PubMed PubMed Central Google Scholar
• Mangiarotti, G. Coupling of transcription and translation in Dictyostelium discoideum nuclei. Biochemistry 38, 3996–4000 (1999).
  CAS PubMed Google Scholar
• Iborra, F. J., Jackson, D. A. & Cook, P. R. Coupled transcription and translation within nuclei of mammalian cells. Science 293, 1139–1142 (2001).This recent paper reports evidence that transcription-coupled translation might take place in the nucleus of mammalian cells.
  CAS PubMed Google Scholar
• Ahn, A. H. & Kunkel, L. M. The structural and functional diversity of dystrophin. Nature Genet. 3, 283–291 (1993).
  CAS PubMed Google Scholar
• Koenig, M. et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am. J. Hum. Genet. 45, 498–506 (1989).
  CAS PubMed PubMed Central Google Scholar
• Shiga, N. et al. Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy. J. Clin. Invest. 100, 2204–2210 (1997).
  CAS PubMed PubMed Central Google Scholar
• Ginjaar, I. B. et al. Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family. Eur. J. Hum. Genet. 8, 793–796 (2000).
  CAS PubMed Google Scholar
• Liu, W., Qian, C. & Francke, U. Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome. Nature Genet. 16, 328–329 (1997).
  CAS PubMed Google Scholar
• Hoffmeyer, S. et al. Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors. Am. J. Hum. Genet. 62, 269–277 (1998).
  CAS PubMed PubMed Central Google Scholar
• Tu, M., Tong, W., Perkins, R. & Valentine, C. R. Predicted changes in pre-mRNA secondary structure vary in their association with exon skipping for mutations in exons 2, 4, and 8 of the Hprt gene and exon 51 of the fibrillin gene. Mutat. Res. 432, 15–32 (2000).
  CAS PubMed Google Scholar
• Valentine, C. R. & Heflich, R. H. The association of nonsense mutation with exon-skipping in hprt mRNA of Chinese hamster ovary cells results from an artifact of RT-PCR. RNA 3, 660–676 (1997).
  CAS PubMed PubMed Central Google Scholar
• Valentine, C. R. The association of nonsense codons with exon skipping. Mutat. Res. 411, 87–117 (1998).A thorough survey of nonsense (and missense) mutations that are associated with skipping of exons in human and rodent genes, which argues that most cases of nonsense-associated exon skipping are due to interference with exon definition or to non-quantitative RNA measurements.
  PubMed Google Scholar
• Muro, A. F. et al. Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display. Mol. Cell. Biol. 19, 2657–2671 (1999).
  CAS PubMed PubMed Central Google Scholar
• Gibson, R. A., Hajianpour, A., Murer-Orlando, M., Buchwald, M. & Mathew, C. G. A nonsense mutation and exon skipping in the Fanconi anaemia group C gene. Hum. Mol. Genet. 2, 797–799 (1993).
  CAS PubMed Google Scholar
• Lo Ten Foe, J. R. et al. Exon 6 skipping in the Fanconi anemia C gene associated with a nonsense/missense mutation (775C→T) in exon 5: the first example of a nonsense mutation in one exon causing skipping of another downstream. Hum. Mutat. (Suppl. 1), S25–S27 (1998).
• Cooper, T. A. & Mattox, W. The regulation of splice-site selection, and its role in human disease. Am. J. Hum. Genet. 61, 259–266 (1997).
  CAS PubMed PubMed Central Google Scholar
• Mazoyer, S. et al. A BRCA1 nonsense mutation causes exon skipping. Am. J. Hum. Genet. 62, 713–715 (1998).
  CAS PubMed PubMed Central Google Scholar
• Liu, H. X., Cartegni, L., Zhang, M. Q. & Krainer, A. R. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nature Genet. 27, 55–58 (2001).In this paper, exon skipping that is associated with a premature termination codon is shown to be due to the inactivation of an exonic splicing enhancer. A missense mutation that similarly disrupts the enhancer motif also causes exon skipping, whereas a nonsense mutation that does not disrupt the motif maintains exon inclusion.
  CAS PubMed Google Scholar
• Kronenberg, M., Siu, G., Hood, L. E. & Shastri, N. The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. Annu. Rev. Immunol. 4, 529–591 (1986).
  CAS PubMed Google Scholar
• Fang, W. et al. Frequent aberrant immunoglobulin gene rearrangements in pro-B cells revealed by a bcl-xL transgene. Immunity 4, 291–299 (1996).
  CAS PubMed Google Scholar
• Hernandez-Boussard, T., Rodriguez-Tome, P., Montesano, R. & Hainaut, P. IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer. Hum. Mutat. 14, 1–8 (1999).
  CAS PubMed Google Scholar
• Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155–165 (1995).
  CAS PubMed Google Scholar
• Lorson, C. L., Hahnen, E., Androphy, E. J. & Wirth, B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl Acad. Sci. USA 96, 6307–6311 (1999).
  CAS PubMed PubMed Central Google Scholar
• Monani, U. R. et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet. 8, 1177–1183 (1999).References 84 and 85 show that a single, translationally silent nucleotide change in exon 7 of SMN1 converts this constitutive exon into an alternative exon. This observation shows why the closely related SMN2 gene acts as a disease modifier in spinal muscular atrophy.
  CAS PubMed Google Scholar
• Lorson, C. L. & Androphy, E. J. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum. Mol. Genet. 9, 259–265 (2000).
  CAS PubMed Google Scholar
• Jablonka, S., Rossoll, W., Schrank, B. & Sendtner, M. The role of SMN in spinal muscular atrophy. J. Neurol. 247 (Suppl. 1), I37–I42 (2000).
  PubMed Google Scholar
• Cartegni, L. & Krainer, A. R. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nature Genet. 2002 March 4 (DOI 10.1038/ng854)In this study, exon 7 in SMN1 is shown to contain an exonic splicing enhancer that is recognized by a specific SR protein. This motif is abrogated by the single nucleotide change in SMN2 that inhibits exon inclusion.
• Lee, V. M., Goedert, M. & Trojanowski, J. Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121–1159 (2001).
  CAS PubMed Google Scholar
• Hasegawa, M., Smith, M. J., Iijima, M., Tabira, T. & Goedert, M. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. FEBS Lett. 443, 93–96 (1999).
  CAS PubMed Google Scholar
• Varani, L. et al. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc. Natl Acad. Sci. USA 96, 8229–8234 (1999).
  CAS PubMed PubMed Central Google Scholar
• D'Souza, I. & Schellenberg, G. D. Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion. J. Biol. Chem. 275, 17700–17709 (2000).
  CAS PubMed Google Scholar
• D'Souza, I. et al. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl Acad. Sci. USA 96, 5598–5603 (1999).
  CAS PubMed PubMed Central Google Scholar
• Hurst, L. D. & Pal, C. Evidence for purifying selection acting on silent sites in BRCA1. Trends Genet. 17, 62–65 (2001).
  CAS PubMed Google Scholar
• Orban, T. I. & Olah, E. Purifying selection on silent sites — a constraint from splicing regulation? Trends Genet. 17, 252–253 (2001).
  CAS PubMed Google Scholar
• Iida, K. & Akashi, H. A test of translational selection at 'silent' sites in the human genome: base composition comparisons in alternatively spliced genes. Gene 261, 93–105 (2000).
  CAS PubMed Google Scholar
• Brookes, A. J. The essence of SNPs. Gene 234, 177–186 (1999).
  CAS PubMed Google Scholar
• Cargill, M. et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genet. 22, 231–238 (1999).
  CAS PubMed Google Scholar
• Sachidanandam, R. et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928–933 (2001).
  CAS PubMed Google Scholar
• Sierakowska, H., Agrawal, S. & Kole, R. Antisense oligonucleotides as modulators of pre-mRNA splicing. Methods Mol. Biol. 133, 223–233 (2000).
  CAS PubMed Google Scholar
• Lim, S. R. & Hertel, K. J. Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3′ splice site pairing. J. Biol. Chem. 276, 45476–45483 (2001).
  CAS PubMed Google Scholar
• Andreassi, C. et al. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum. Mol. Genet. 10, 2841–2849 (2001).
  CAS PubMed Google Scholar
• Chang, J. G. et al. Treatment of spinal muscular atrophy by sodium butyrate. Proc. Natl Acad. Sci. USA 98, 9808–9813 (2001).
  CAS PubMed PubMed Central Google Scholar
• Zhang, M. L., Lorson, C. L., Androphy, E. J. & Zhou, J. An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA. Gene Ther. 8, 1532–1538 (2001).
  CAS PubMed Google Scholar
• Tuerk, C. & Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505–510 (1990).
  CAS PubMed Google Scholar
• Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K. & Pease, L. R. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77, 61–68 (1989).
  CAS PubMed Google Scholar
• Cooper, T. A. In vivo SELEX in vertebrate cells. Methods Mol. Biol. 118, 405–417 (1999).
  CAS PubMed Google Scholar
• Maquat, L. E. in Translational Control of Gene Expression (eds Sonenberg, N., Hershey, J. W. B. & Mathews, M. B.) 849–868 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 2000).
  Google Scholar
• Le Hir, H., Izaurralde, E., Maquat, L. E. & Moore, M. J. The spliceosome deposits multiple proteins 20–24 nucleotides upstream of mRNA exon–exon junctions. EMBO J. 19, 6860–6869 (2000).This study shows that there is an exon–junction complex that retains information about intron position after the completion of pre-mRNA splicing. This complex might be used to distinguish authentic from premature termination codons during NMD.
  CAS PubMed PubMed Central Google Scholar
• Ishigaki, Y., Li, X., Serin, G. & Maquat, L. E. Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20. Cell 106, 607–617 (2001).
  CAS PubMed Google Scholar
• Hofmann, Y., Lorson, C. L., Stamm, S., Androphy, E. J. & Wirth, B. Htra2-β1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc. Natl Acad. Sci. USA 97, 9618–9623 (2000).
  CAS PubMed PubMed Central Google Scholar
• Cavaloc, Y., Bourgeois, C. F., Kister, L. & Stévenin, J. The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers. RNA 5, 468–483 (1999).
  CAS PubMed PubMed Central Google Scholar
• Lou, H., Neugebauer, K. M., Gagel, R. F. & Berget, S. M. Regulation of alternative polyadenylation by U1 snRNPs and SRp20. Mol. Cell. Biol. 18, 4977–4985 (1998).
  CAS PubMed PubMed Central Google Scholar
• Tacke, R., Chen, Y. & Manley, J. L. Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: creation of an SRp40-specific splicing enhancer. Proc. Natl Acad. Sci. USA 94, 1148–1153 (1997).
  CAS PubMed PubMed Central Google Scholar
• Tacke, R., Tohyama, M., Ogawa, S. & Manley, J. L. Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. Cell 93, 139–148 (1998).
  CAS PubMed Google Scholar
• Ozsahin, H. et al. Adenosine deaminase deficiency in adults. Blood 89, 2849–2855 (1997).
  CAS PubMed Google Scholar
• Das, S. et al. Diverse mutations in patients with Menkes disease often lead to exon skipping. Am. J. Hum. Genet. 55, 883–889 (1994).
  CAS PubMed PubMed Central Google Scholar
• Kerem, E. et al. A missense cystic fibrosis transmembrane conductance regulator mutation with variable phenotype. Pediatrics 100, E5 (1997).
  CAS PubMed Google Scholar
• Tzetis, M., Efthymiadou, A., Doudounakis, S. & Kanavakis, E. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621 + 3A → G, 2751 + 2T → A, 296 + 1G → C, 1717-9T → C-D565G) and one nonsense mutation (E822X) in the CFTR gene. Hum. Genet. 109, 592–601 (2001).
  CAS PubMed Google Scholar
• Theophilus, B. D., Enayat, M. S., Williams, M. D. & Hill, F. G. Site and type of mutations in the factor VIII gene in patients and carriers of haemophilia A. Haemophilia 7, 381–391 (2001).
  CAS PubMed Google Scholar
• Dreumont, N. et al. A missense mutation (Q279R) in the fumarylacetoacetate hydrolase gene, responsible for hereditary tyrosinemia, acts as a splicing mutation. BMC Genet. 2, 9 (2001).
• Babcock, D., Gasner, C., Francke, U. & Maslen, C. A single mutation that results in an Asp to His substitution and partial exon skipping in a family with congenital contractural arachnodactyly. Hum. Genet. 103, 22–28 (1998).
  CAS PubMed Google Scholar
• Wang, X. Molecular characterization of a novel defect occurring de novo associated with erythropoietic protoporphyria. Biochim. Biophys. Acta 1316, 149–152 (1996).
  PubMed Google Scholar
• Wakamatsu, N., Kobayashi, H., Miyatake, T. & Tsuji, S. A novel exon mutation in the human β-hexosaminidase β-subunit gene affects 3′ splice site selection. J. Biol. Chem. 267, 2406–2413 (1992).
  CAS PubMed Google Scholar
• Mustajoki, S. et al. Three splicing defects, an insertion, and two missense mutations responsible for acute intermittent porphyria. Hum. Genet. 102, 541–548 (1998).
  CAS PubMed Google Scholar
• Kanai, N. et al. A G to A transition at the last nucleotide of exon 6 of the γc gene (868G → A) may result in either a splice or missense mutation in patients with X-linked severe combined immunodeficiency. Hum. Genet. 104, 36–42 (1999).
  CAS PubMed Google Scholar
• Vockley, J. et al. Exon skipping in IVD RNA processing in isovaleric acidemia caused by point mutations in the coding region of the IVD gene. Am. J. Hum. Genet. 66, 356–367 (2000).
  CAS PubMed PubMed Central Google Scholar
• Nystrom-Lahti, M. et al. Missense and nonsense mutations in codon 659 of MLH1 cause aberrant splicing of messenger RNA in HNPCC kindreds. Genes Chromosomes Cancer 26, 372–375 (1999).
  CAS PubMed Google Scholar
• Chun, K. et al. Mutations in the X-linked E1α subunit of pyruvate dehydrogenase: exon skipping, insertion of duplicate sequence, and missense mutations leading to the deficiency of the pyruvate dehydrogenase complex. Am. J. Hum. Genet. 56, 558–569 (1995).
  CAS PubMed PubMed Central Google Scholar
• Vuillaumier-Barrot, S. et al. Characterization of the 415G → A (E139K) PMM2 mutation in carbohydrate-deficient glycoprotein syndrome type Iα disrupting a splicing enhancer resulting in exon 5 skipping. Hum. Mutat. 14, 543–544 (1999).
  CAS PubMed Google Scholar
• Huang, C. H. et al. Molecular basis for Rh(null) syndrome: identification of three new missense mutations in the Rh50 glycoprotein gene. Am. J. Hematol. 62, 25–32 (1999).
  CAS PubMed Google Scholar
• Montera, M. et al. A silent mutation in exon 14 of the APC gene is associated with exon skipping in a FAP family. J. Med. Genet. 38, 863–867 (2001).
  CAS PubMed PubMed Central Google Scholar
• Hellwinkel, O. J. et al. A unique exonic splicing mutation in the human androgen receptor gene indicates a physiologic relevance of regular androgen receptor transcript variants. J. Clin. Endocrinol. Metab. 86, 2569–2575 (2001).
  CAS PubMed Google Scholar
• Chen, W. et al. Silent nucleotide substitution in the sterol 27-hydroxylase gene (CYP27) leads to alternative pre-mRNA splicing by activating a cryptic 5′ splice site at the mutant codon in cerebrotendinous xanthomatosis patients. Biochemistry 37, 4420–4428 (1998).
  CAS PubMed Google Scholar
• Ploos van Amstel, J. K. et al. Hereditary tyrosinemia type 1: novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype–phenotype relationship. Hum. Genet. 97, 51–59 (1996).
  CAS PubMed Google Scholar
• Akli, S. et al. A 'G' to 'A' mutation at position –1 of a 5′ splice site in a late infantile form of Tay-Sachs disease. J. Biol. Chem. 265, 7324–7330 (1990).
  CAS PubMed Google Scholar
• Llewellyn, D. H. et al. Acute intermittent porphyria caused by defective splicing of porphobilinogen deaminase RNA: a synonymous codon mutation at 22 bp from the 5′ splice site causes skipping of exon 3. J. Med. Genet. 33, 437–438 (1996).
  CAS PubMed PubMed Central Google Scholar
• Jin, Y. et al. Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection. J. Clin. Invest. 98, 1745–1754 (1996).
  CAS PubMed PubMed Central Google Scholar
• Ries, S. et al. Different missense mutations in histidine-108 of lysosomal acid lipase cause cholesteryl ester storage disease in unrelated compound heterozygous and hemizygous individuals. Hum. Mutat. 12, 44–51 (1998).
  CAS PubMed Google Scholar
• Kohonen-Corish, M. et al. RNA-based mutation screening in hereditary nonpolyposis colorectal cancer. Am. J. Hum. Genet. 59, 818–824 (1996).
  CAS PubMed PubMed Central Google Scholar
• Fahsold, R. et al. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am. J. Hum. Genet. 66, 790–818 (2000).
  CAS PubMed PubMed Central Google Scholar
• Chao, H. K., Hsiao, K. J. & Su, T. S. A silent mutation induces exon skipping in the phenylalanine hydroxylase gene in phenylketonuria. Hum. Genet. 108, 14–19 (2001).
  CAS PubMed Google Scholar
• De Meirleir, L. et al. Aberrant splicing of exon 6 in the pyruvate dehydrogenase-E1α mRNA linked to a silent mutation in a large family with Leigh's encephalomyelopathy. Pediatr. Res. 36, 707–712 (1994).
  CAS PubMed Google Scholar
• Kanno, H. et al. Frame shift mutation, exon skipping, and a two-codon deletion caused by splice site mutations account for pyruvate kinase deficiency. Blood 89, 4213–4218 (1997).
  CAS PubMed Google Scholar
• Jacobsen, M. et al. A point mutation in PTPRC is associated with the development of multiple sclerosis. Nature Genet. 26, 495–499 (2000).
  CAS PubMed Google Scholar
• Imamura, T., Okano, Y., Shintaku, H., Hase, Y. & Isshiki, G. Molecular characterization of 6-pyruvoyl-tetrahydropterin synthase deficiency in Japanese patients. J. Hum. Genet. 44, 163–168 (1999).
  CAS PubMed Google Scholar
• Auricchio, A. et al. Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease. Am. J. Hum. Genet. 64, 1216–1221 (1999).
  CAS PubMed PubMed Central Google Scholar
• Ferrari, S. et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc. Natl Acad. Sci. USA 98, 12614–12619 (2001).
  CAS PubMed PubMed Central Google Scholar
• Mendez, M. et al. Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles. Am. J. Hum. Genet. 63, 1363–1375 (1998).
  CAS PubMed PubMed Central Google Scholar